Canaan
Portfolio in Germany · Israel: 2 funded startups tracked by Uback, 1 of them in a ranking.
Portfolio on Uback2startups, 2 countries
In a ranking1ranked by AI-estimated valuation
On the Radar1eligible, not ranked
Latest deal trackedJun 2026Rylo
Portfolio on Uback
Sorted by Uback rank, then Radar by last round| Company | Uback | Sector | Round backed | Valuation (AI) |
|---|---|---|---|---|
| CatalYm | #34 Germany | Biotech › cancer immunotherapy | Series D · USD 150M · Jul 2024 | Hundreds of M$ |
| Rylo | Radar | AI › speech and sign-language translation | Growth · USD 85M · Jun 2026 | Not estimated |
Only startups that meet Uback’s eligibility rules are shown. Amounts are round sizes, not the fund’s share. Rounds as reported by public sources.
By sector
Deals tracked per year
12024
02025
12026
Co-investors
General Catalyst · Bayer · Novo Holdings
Investors that joined the same rounds, as reported by public sources.
Last updated: Oct 2026Report a missing dealReport an error
Uback is a content publisher. It provides no investment advice, receives no mandate and takes part in no transaction.